Abstract
The women' s mammography segment is poised for a major new phase of growth
fueled by the availability of new technology coming out of the computer and
digital areas and the higher interest of individual patients and general
healthcare consumers to take charge of their own health status. Continuous
improvements in technology are resulting in a growing number of new imaging
diagnostic tests that combine high levels of accuracy with rapid, easy-to-use
product formats. Digital mammography is driving more screening programs. The
emphasis in this TriMark Publications report is on those companies and
products that are actively developing and marketing clinical laboratory
instrumentation and reagents and supplies for performing diagnostic tests on
conditions specifically related to women' s health.
This study concentrates on the mammography market segment in large worldwide
markets such as the U.S., Japan and Europe. Certain areas that are not covered
include what is generally characterized as digital imaging techniques
instruments and reagents, PACS or other data storage methods, or other medical
imaging technologies, although many of the instruments, reagents and
techniques in the mammography market segment are intimately associated with
these broader areas. Specialty areas in medical imaging are touched upon,
since these segments are frequently a part of the overall analytical focus of
companies marketing general mammography equipment. However, no effort is made
to quantify the size of this broader market.
|